Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Orthopaedic Journal of Sports Medicine
|
September 10, 2021
Impact of Patellar Tendinopathy on Player Performance in the National Basketball Association
Toufic R Jildeh, Patrick Buckley, Muhammad J Abbas, et al.
The American Journal of Sports Medicine
|
August 7, 2019
Effect of Concussions on the Performance of Running Backs and Wide Receivers in the National Football League
Toufic R Jildeh, Kelechi R Okoroha, Kevin A Taylor, et al.
Journal of Surgical Orthopaedic Advances
|
September 5, 2023
Availability of Consumer Prices for Arthroscopic Meniscus Surgery
Toufic R Jildeh, Patrick Buckley, Muhammad J Abbas, et al.
Arthroscopy, Sports Medicine, and Rehabilitation
|
January 3, 2022
Social Media Use Continues to Increase Among Orthopaedic Residency Programs in the United States
Muhammad J Abbas, Toufic R Jildeh, Lafi S Khalil, et al.
JBJS Reviews
|
March 31, 2022
Patellar Tendinopathy: Critical Analysis Review of Current Nonoperative Treatments
Erick M Marigi, Patrick Buckley, Farzad Razi, et al.
American Journal of Hematology
|
July 25, 2003
High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series
Jeffrey Talbot, David A Rizzieri, Carlos M DeCastro, et al.
Cancer Letters
|
May 12, 2015
The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro
Olga Piskareva, Harry Harvey, John Nolan, et al.
Cancer Genetics
|
August 3, 2014
Rhabdoid tumor: the Irish experience 1986-2013
Alice Uwineza, Harinder Gill, Patrick Buckley, et al.
Clinical Neuropathology
|
July 3, 2014
Genetic features of oligodendrogliomas and presence of seizures. The relationship of seizures and genetics in LGOs
Linda Mulligan, Elizabeth Ryan, Margaret O'Brien, et al.
Clinical Lymphoma
|
September 30, 2004
Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma
Jeffrey Talbot, Valerie K Ibom, David A Rizzieri, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Orthopaedic Journal of Sports Medicine
|
September 10, 2021
Impact of Patellar Tendinopathy on Player Performance in the National Basketball Association
Toufic R Jildeh, Patrick Buckley, Muhammad J Abbas, et al.
The American Journal of Sports Medicine
|
August 7, 2019
Effect of Concussions on the Performance of Running Backs and Wide Receivers in the National Football League
Toufic R Jildeh, Kelechi R Okoroha, Kevin A Taylor, et al.
Journal of Surgical Orthopaedic Advances
|
September 5, 2023
Availability of Consumer Prices for Arthroscopic Meniscus Surgery
Toufic R Jildeh, Patrick Buckley, Muhammad J Abbas, et al.
Arthroscopy, Sports Medicine, and Rehabilitation
|
January 3, 2022
Social Media Use Continues to Increase Among Orthopaedic Residency Programs in the United States
Muhammad J Abbas, Toufic R Jildeh, Lafi S Khalil, et al.
JBJS Reviews
|
March 31, 2022
Patellar Tendinopathy: Critical Analysis Review of Current Nonoperative Treatments
Erick M Marigi, Patrick Buckley, Farzad Razi, et al.
American Journal of Hematology
|
July 25, 2003
High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series
Jeffrey Talbot, David A Rizzieri, Carlos M DeCastro, et al.
Cancer Letters
|
May 12, 2015
The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro
Olga Piskareva, Harry Harvey, John Nolan, et al.
Cancer Genetics
|
August 3, 2014
Rhabdoid tumor: the Irish experience 1986-2013
Alice Uwineza, Harinder Gill, Patrick Buckley, et al.
Clinical Neuropathology
|
July 3, 2014
Genetic features of oligodendrogliomas and presence of seizures. The relationship of seizures and genetics in LGOs
Linda Mulligan, Elizabeth Ryan, Margaret O'Brien, et al.
Clinical Lymphoma
|
September 30, 2004
Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma
Jeffrey Talbot, Valerie K Ibom, David A Rizzieri, et al.
Page
of 3